Pfizer Covid jab ‘90% effective against hospitalisation for at least 6 months’

Summary by Ground News
Vaccination with two doses of the Pfizer jab stays highly effective against severe COVID, including the Delta variant. Pfizer and healthcare provider Kaiser Permanente looked at records from 3.4 million residents of southern California. After an average period of three to four months, fully vaccinated people were found to be 73% protected against infection.
8 months ago·London, United Kingdom

News Articles

Pfizer jab ‘effective at preventing hospital admission for at least six months’

Two doses of the jab are 90% effective against Covid-19 hospital admission for all coronavirus variants, researchers found.

8 months ago·Los Angeles, United States
Read Full Article
Times of India

pfizer: ‘Pfizer vax provides 90% protection against hospitalisation for 6 months’

The Pfizer-BioNTech Covid vaccine is 90% effective at preventing hospitalisation for up to six months, with no signs of waning during that time period, according to a large new US study conducted by researchers at Pfizer and Kaiser Permanente. The vaccine also provides powerful protection against the highly contagious Delta variant, the scientists found.

8 months ago·Mumbai, India
Read Full Article
Reuters

Pfizer/BioNTech COVID-19 vaccine effectiveness drops after 6 months, study shows

The effectiveness of the Pfizer Inc /BioNTech SE vaccine in preventing infection by the coronavirus dropped to 47% from 88% six months after the second dose, according to data published on Monday that U.S. health agencies considered when deciding on the need for booster shots.

8 months ago·United Kingdom
Read Full Article
The Guardian

Pfizer Covid jab ‘90% effective against hospitalisation for at least 6 months’

Study shows protection against severe illness stays high, but scientists say boosters key to stopping spread of infection

8 months ago·London, United Kingdom
Read Full Article
News18 India

Pfizer/BioNTech COVID-19 Vaccine Effectiveness Drops After 6 Months -study

The effectiveness of the Pfizer Inc/BioNTech SE vaccine in preventing infection by the coronavirus dropped to 47% from 88% six months after the second dose, according to data published on Monday that U.S. health agencies considered when deciding on the need for booster shots.

8 months ago·India
Read Full Article
CTV News

Pfizer COVID-19 vaccine antibodies disappear in many by 7 months, study shows

Six months after receiving the second dose of the two-shot vaccine from Pfizer Inc and BioNTech SE, many recipients no longer have vaccine-induced antibodies that can immediately neutralize worrisome variants of the coronavirus, a new study suggests.

8 months ago·Toronto, Canada
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

41% of the sources are Center
The Guardian
CBS Local
Global News
NDTV
abc News
Hindustan Times
+10
Reuters
CTV News
CNBC
IBTimes
RTÉ
The Hill
+15
Times of India
News18 India
ABS-CBN
The Sun
Evening Standard
Khaleej Times
+1
The Star Kuala Lumpur
OAN
The Daily Wire
CBN
Zero Hedge
InfoWars
NewsWars
Red Voice Media
L 31%
C 40%
R 29%
Untracked bias
See less detail